世界中医药
文章摘要
引用本文:张晓雨1,钟长鸣2,关曼柯2,何天麦2,韩松洁2,孙杨2,郑蕊2,胡嘉元2,石兆峰2,杨欣宇2,代倩倩2,商洪才2.心肌梗死中医防治临床研究证据图[J].世界中医药,2019,(10):.  
心肌梗死中医防治临床研究证据图
Clinical Study on Traditional Chinese Medicine for Myocardial Infarction Prevention and Treatment:An Evidence Map
投稿时间:2019-09-10  
DOI:10.3969/j.issn.1673-7202.2019.10.001
中文关键词:  中医  心肌梗死  临床研究  证据图  综述  方法学  系统评价  优先领域
English Keywords:Traditional Chinese medicine  Myocardial infarction  Clinical study  Evidence map  Review  Methodology  Systematic review  Priority field
基金项目:国家重点研发计划“中医药现代化研究”重点专项项目(2017YFC1700400,2017YFC1700402);国家自然科学基金杰出青年项目(81725024)
作者单位
张晓雨1,钟长鸣2,关曼柯2,何天麦2,韩松洁2,孙杨2,郑蕊2,胡嘉元2,石兆峰2,杨欣宇2,代倩倩2,商洪才2 1 北京中医药大学北京100029 2 北京中医药大学东直门医院北京100700 
摘要点击次数: 667
全文下载次数: 813
中文摘要:
      目的:应用证据图方法,系统检索与梳理心肌梗死中医防治临床研究文献,了解该领域证据分布。方法:检索中国知网、万方、维普、PubMed,EMbase,Web of Science数据库,时限从2000年1月至2018年11月。纳入心肌梗死中医防治临床研究、系统评价、指南与路径研究。采用文字描述结合图表分析证据分布特征。结果:纳入文献1 664篇,分析了临床研究发表年度趋势、研究类型、研究规模;证候、体质临床研究;中医疗法类别及主要方案;中医防治方案的评价领域、应用调查、作用环节、干预时机、适应人群和病症;系统评价方法学质量及结论;指南与临床路径研究。结论:目前在心肌梗死中医病因及体质研究、中医非药物疗法、生命质量及情志心理疗效评价、预防作用及超早期干预(包括急救)领域研究证据较少,临床研究和系统评价质量有待提高。
English Summary:
      To systematically retrieve and summarize clinical study literatures on traditional Chinese medicine(TCM)for myocardial infarction(MI)prevention and treatment by using the method of evidence map,and to understand evidence distribution in this field.Methods:The clinical study,systematic review,guidelines and path study related to TCM for MI prevention and treatment,published between January 2000 and November 2018 were included after searching databases like CNKI,Wanfang,VIP,PubMed,EMbase and Web of Science.The distribution of evidence was analyzed by text description,tables and graphs.Results:A total of 1664 literatures were included.They were analyzed in following aspects:annual trend of publication,study type and size of clinical study; clinical study on syndromes and constitutions; classifications of TCM therapeutic methods and main schemes; evaluation areas,application and investigation,link of action,intervention timing,intended population,diseases and symptoms of TCM therapeutic schemes; systematic review on quality and conclusion of methodology; guidelines and clinical path study.Conclusion:At present,there is less evidence related to TCM etiology and constitutions in MI,TCM non-medicine therapy,efficacy evaluation on quality of life and emotional psychology,preventive effects and ultra-early intervention(including first aid).The quality of clinical study and systematic review needs to be improved.
查看全文  查看/发表评论  下载PDF阅读器